Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2015

Ausgabe 3/2015

Inhaltsverzeichnis ( 23 Artikel )

01.06.2015 | Review | Ausgabe 3/2015

VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis

Lucas Vieira dos Santos, Marcelo Rocha Cruz, Gilberto de Lima Lopes, Joao Paulo da Silveira Nogueira Lima

01.06.2015 | Review | Ausgabe 3/2015

Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival

Lingeng Lu, Hongmei Zeng, Xinsheng Gu, Wenxue Ma

01.06.2015 | Preclinical study | Ausgabe 3/2015

CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells

Delphine R. Boulbes, Gaurav B. Chauhan, Quanri Jin, Chandra Bartholomeusz, Francisco J. Esteva

01.06.2015 | Preclinical study | Ausgabe 3/2015

Relevance of βGal–βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients

Karin Milde-Langosch, Dina Schütze, Leticia Oliveira-Ferrer, Harriet Wikman, Volkmar Müller, Patrick Lebok, Klaus Pantel, Christine Schröder, Isabell Witzel, Udo Schumacher

01.06.2015 | Preclinical Study | Ausgabe 3/2015

Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing

Yong Wu, Marianna Sarkissyan, Eva Mcghee, Sangkyu Lee, Jaydutt V. Vadgama

01.06.2015 | Preclinical study | Ausgabe 3/2015

Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer

Shaham Beg, Abdul K. Siraj, Sarita Prabhakaran, Zeenath Jehan, Dahish Ajarim, Fouad Al-Dayel, Asma Tulbah, Khawla S. Al-Kuraya

01.06.2015 | Preclinical study | Ausgabe 3/2015 Open Access

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer

Hua Zhang, Nicos Angelopoulos, Yichen Xu, Arnhild Grothey, Joao Nunes, Justin Stebbing, Georgios Giamas

01.06.2015 | Clinical Trial | Ausgabe 3/2015

Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer

Christoph Scholz, U. Andergassen, P. Hepp, C. Schindlbeck, Thomas W. P. Friedl, N. Harbeck, M. Kiechle, H. Sommer, H. Hauner, K. Friese, B. Rack, W. Janni

01.06.2015 | Clinical Trial | Ausgabe 3/2015

Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis

Ginés Luengo-Gil, Enrique González-Billalabeitia, Asunción Chaves-Benito, Elena García Martínez, Elisa García Garre, Vicente Vicente, Francisco Ayala de la Peña

01.06.2015 | Clinical trial | Ausgabe 3/2015

Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)

Kathryn J. Ruddy, Hao Guo, William Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew J. Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Beth A. Overmoyer, Clifford Hudis, Ian E. Krop, Harold J. Burstein, Eric P. Winer, Ann H. Partridge, Sara M. Tolaney

01.06.2015 | Clinical Trial | Ausgabe 3/2015

Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study

Miguel J. Gil-Gil, M. Bellet, S. Morales, B. Ojeda, L. Manso, C. Mesia, E. Garcia-Martínez, N. Martinez-Jáñez, M. Melé, A. Llombart, S. Pernas, P. Villagrasa, C. Blasco, J. Baselga

01.06.2015 | Clinical trial | Ausgabe 3/2015

Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer

Rong Liu, Qiao-Li Lv, Jing Yu, Lei Hu, Li-Hua Zhang, Yu Cheng, Hong-Hao Zhou

01.06.2015 | Clinical Trial | Ausgabe 3/2015

Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes

Hee Jin Lee, Jeong-Ju Lee, In Hye Song, In Ah Park, Jun Kang, Jong Han Yu, Jin-Hee Ahn, Gyungyub Gong

01.06.2015 | Clinical trial | Ausgabe 3/2015

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

Virginia G. Kaklamani, Jacqueline S. Jeruss, Elisha Hughes, Kalliopi Siziopikou, Kirsten M. Timms, Alexander Gutin, Victor Abkevich, Zaina Sangale, Cara Solimeno, Krystal L. Brown, Joshua Jones, Anne-Renee Hartman, Caitlin Meservey, Borko Jovanovic, Irene Helenowski, Seema A. Khan, Kevin Bethke, Nora Hansen, Regina Uthe, Sara Giordano, Steven Rosen, Kent Hoskins, Jamie Von Roenn, Sarika Jain, Vamsi Parini, William Gradishar

01.06.2015 | Epidemiology | Ausgabe 3/2015

Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis

William W. L. Wong, Lisa K. Hicks, Hong-Anh Tu, Kathleen I. Pritchard, Murray D. Krahn, Jordan J. Feld, Kelvin K. Chan

01.06.2015 | Epidemiology | Ausgabe 3/2015

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry

Tehillah S. Menes, Mary Beth Terry, David Goldgar, Irene L. Andrulis, Julia A. Knight, Esther M. John, Yuyan Liao, Melissa Southey, Alexander Miron, Wendy Chung, Saundra S. Buys

01.06.2015 | Epidemiology | Ausgabe 3/2015

Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study

Reema A. Karasneh, Liam J. Murray, Úna C. Mc Menamin, Carmel M. Hughes, Chris R. Cardwell

01.06.2015 | Epidemiology | Ausgabe 3/2015

TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li–Fraumeni family

Sonja Kappel, Elisabeth Janschek, Brigitte Wolf, Margaretha Rudas, Bela Teleky, Raimund Jakesz, Daniela Kandioler

01.06.2015 | Epidemiology | Ausgabe 3/2015

Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients

Patricia J. Hollen, Pavlos Msaouel, Richard J. Gralla

01.06.2015 | Epidemiology | Ausgabe 3/2015

Racial and ethnic differences in risk of second primary cancers among breast cancer survivors

Gregory S. Calip, Ernest H. Law, Naomi Y. Ko

01.06.2015 | Epidemiology | Ausgabe 3/2015

Racial differences in outcomes for patients with metastatic breast cancer by disease subtype

Ines Vaz-Luis, Nancy U. Lin, Nancy L. Keating, William T. Barry, Huichuan Lii, Eric P. Winer, Rachel A. Freedman

01.06.2015 | Brief Report | Ausgabe 3/2015

Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer

Savas D. Soysal, Incken B. Kilic, Christian R. A. Regenbrecht, Sandra Schneider, Simone Muenst, Nerbil Kilic, Uwe Güth, Manfred Dietel, Luigi M. Terracciano, Ergin Kilic

01.06.2015 | Letter to the Editor | Ausgabe 3/2015

Identification of clinically relevant alterations in phyllodes tumor of the breast by amplicon-based next-generation sequencing

Julia Y. S. Tsang, Edna May L. Go, Gary M. Tse

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.